Reperfusion Strategies in Acute Coronary Syndromes (Q22241917)

inferred from title

author

Christopher B. Granger

4

C. B. Granger

Christopher B

Granger

1 reference

7 February 2023

A. Bagai

1

Akshay

Bagai

1 reference

24902975

7 February 2023

G. D. Dangas

series ordinal

2

author given names

George D

author last names

Dangas

1 reference

24902975

7 February 2023

G. W. Stone

series ordinal

3

author given names

Gregg W

author last names

Stone

1 reference

24902975

Immediate vs delayed intervention for acute coronary syndromes: a randomized clinical trial

7 February 2023

language of work or name

English

0 references

publication date

5 June 2014

0 references

published in

Circulation Research

0 references

volume

114

0 references

issue

12

0 references

page(s)

1918-1928

0 references

cites work

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

System delay and mortality among patients with STEMI treated with primary percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: the CRISP AMI randomized trial

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Association Between Adoption of Evidence-Based Treatment and Survival for Patients With ST-Elevation Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Association of door-in to door-out time with reperfusion delays and outcomes among patients transferred for primary percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction: is the slope of the curve the shape of the future?

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Decline in Rates of Death and Heart Failure in Acute Coronary Syndromes, 1999-2006

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Implementation of a statewide system for coronary reperfusion for ST-segment elevation myocardial infarction.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Multivessel coronary artery disease: a key predictor of short-term prognosis after reperfusion therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Culprit-only or multivessel revascularization in patients with acute coronary syndromes: an American College of Cardiology National Cardiovascular Database Registry report

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Trends in reperfusion strategies, door-to-needle and door-to-balloon times, and in-hospital mortality among patients with ST-segment elevation myocardial infarction enrolled in the National Registry of Myocardial Infarction from 1990 to 2006.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

The Study Of LoSmapimod treatment on inflammation and InfarCtSizE (SOLSTICE): Design and rationale

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Rationale and design of the EMBRACE STEMI study: a phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

A prospective regional registry of ST-elevation myocardial infarction in Central Romania: impact of the Stent for Life Initiative recommendations on patient outcomes

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Regional systems of care demonstration project: Mission: Lifeline STEMI Systems Accelerator: design and methodology

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

The impact of prehospital activation of the cardiac catheterization team on time to treatment for patients presenting with ST-segment-elevation myocardial infarction.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Prehospital Delay in Patients With Acute Coronary Syndromes (from the Global Registry of Acute Coronary Events [GRACE])

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Transferring patients with ST-segment elevation myocardial infarction for mechanical reperfusion: a meta-regression analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

In unstable angina or non-ST-segment acute coronary syndrome, should patients with multivessel coronary artery disease undergo multivessel or culprit-only stenting?

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Utilization and impact of pre-hospital electrocardiograms for patients with acute ST-segment elevation myocardial infarction: data from the NCDR (National Cardiovascular Data Registry) ACTION (Acute Coronary Treatment and Intervention Outcomes Netwo

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

National efforts to improve door-to-balloon time results from the Door-to-Balloon Alliance

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Coronary responses and differential mechanisms of late stent thrombosis attributed to first-generation sirolimus- and paclitaxel-eluting stents

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Prospective, Randomized, Multicenter Evaluation of a Polyethylene Terephthalate Micronet Mesh-Covered Stent (MGuard) in ST-Segment Elevation Myocardial Infarction: The MASTER Trial

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

A campaign to improve the timeliness of primary percutaneous coronary intervention: Door-to-Balloon: An Alliance for Quality

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Cardioprotective role of remote ischemic periconditioning in primary percutaneous coronary intervention: enhancement by opioid action

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Surgical versus percutaneous revascularization for multivessel disease in patients with acute coronary syndromes: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Self-expanding versus balloon-expandable stents in acute myocardial infarction: results from the APPOSITION II study: self-expanding stents in ST-segment elevation myocardial infarction

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Emergency medical services as a strategy for improving ST-elevation myocardial infarction system treatment times

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Reperfusion treatment of ST-elevation acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Prehospital delay in patients hospitalized with heart attack symptoms in the United States: the REACT trial. Rapid Early Action for Coronary Treatment (REACT) Study Group

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Extent of, and factors associated with, delay to hospital presentation in patients with acute coronary disease (the GRACE registry)

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Future treatment strategies in ST-segment elevation myocardial infarction

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Incidence of cardiac arrest during self-transport for chest pain

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries f

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Acute coronary syndromes. STREAMlining care for patients with STEMI

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Thrombus aspiration during primary percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

A citywide protocol for primary PCI in ST-segment elevation myocardial infarction

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Early versus Delayed Invasive Intervention in Acute Coronary Syndromes

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Routine early angioplasty after fibrinolysis for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Door-to-balloon time and mortality among patients undergoing primary PCI.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Intraaortic balloon support for myocardial infarction with cardiogenic shock

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Strategies for multivessel revascularization in patients with diabetes

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Fibrinolysis or Primary PCI in ST-Segment Elevation Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Randomized Trial of Preventive Angioplasty in Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Thrombus aspiration during ST-segment elevation myocardial infarction

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Time to treatment in patients with STEMI.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Myocardial reperfusion injury.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Strategies for reducing the door-to-balloon time in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology:

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Delay to reperfusion in patients with acute myocardial infarction presenting to acute care hospitals: an international perspective

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: a meta-analysis

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Urban and rural implementation of pre-hospital diagnosis and direct referral for primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

1 reference

7 January 2021

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Improved long-term clinical outcomes in patients with ST-elevation myocardial infarction undergoing remote ischaemic conditioning as an adjunct to primary percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Culprit-only or multivessel percutaneous coronary stenting in patients with non-ST-segment elevation acute coronary syndromes: one-year follow-up

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Association of door-to-balloon time and mortality in patients admitted to hospital with ST elevation myocardial infarction: national cohort study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Recognition of ST elevation by paramedics

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Long-term impact of multivessel disease on cause-specific mortality after ST elevation myocardial infarction treated with reperfusion therapy

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Rationale and Design of the MITOCARE Study: A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of TRO40303 for the Reduction of Reperfusion Injury in Patients Undergoing Percutaneous Coro

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Use of emergency medical services in acute myocardial infarction and subsequent quality of care: observations from the National Registry of Myocardial Infarction 2

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Transfer for primary angioplasty versus immediate thrombolysis in acute myocardial infarction: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction—Executive Summary

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Heart disease and stroke statistics--2014 update: a report from the American Heart Association

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

1 reference

7 January 2021

2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/Non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiol

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Cardioprotective effects of ischemic postconditioning in patients treated with primary percutaneous coronary intervention, evaluated by magnetic resonance.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Bypassing the emergency department and time to reperfusion in patients with prehospital ST-segment-elevation: findings from the reperfusion in acute myocardial infarction in Carolina Emergency Departments project.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Postconditioning the human heart

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Recommendation to Develop Strategies to Increase the Number of ST-Segment–Elevation Myocardial Infarction Patients With Timely Access to Primary Percutaneous Coronary Intervention

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Long-term benefit of postconditioning

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Intracoronary Compared With Intravenous Bolus Abciximab Application in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Angioplasty strategies in ST-segment-elevation myocardial infarction: part I: primary percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating the 200

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Use of emergency medical service transport among patients with ST-segment-elevation myocardial infarction: findings from the National Cardiovascular Data Registry Acute Coronary Treatment Intervention Outcomes Network Registry-Get With The Guideline

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Intracoronary versus intravenous administration of abciximab in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: the comparison of intracoronary versus intraveno

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Rates of cardiac catheterization cancelation for ST-segment elevation myocardial infarction after activation by emergency medical services or emergency physicians: results from the North Carolina Catheterization Laboratory Activation Registry

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Benefit of transferring ST-segment-elevation myocardial infarction patients for percutaneous coronary intervention compared with administration of onsite fibrinolytic declines as delays increase

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Improvements in door-to-balloon time in the United States, 2005 to 2010.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Expansion of a regional ST-segment-elevation myocardial infarction system to an entire state

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

The impact of a statewide pre-hospital STEMI strategy to bypass hospitals without percutaneous coronary intervention capability on treatment times.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Ischemic postconditioning during primary percutaneous coronary intervention: the effects of postconditioning on myocardial reperfusion in patients with ST-segment elevation myocardial infarction (POST) randomized trial

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Emergency department bypass for ST-Segment-elevation myocardial infarction patients identified with a prehospital electrocardiogram: a report from the American Heart Association Mission: Lifeline program

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Clinical efficacy and safety of intracoronary vs. intravenous abciximab administration in STEMI patients undergoing primary percutaneous coronary intervention: a meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Paramedic contact to balloon in less than 90 minutes: a successful strategy for st-segment elevation myocardial infarction bypass to primary percutaneous coronary intervention in a canadian emergency medical system

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

EMS activation of the cardiac catheterization laboratory is associated with process improvements in the care of myocardial infarction patients

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021

Effect of prehospital cardiac catheterization lab activation on door-to-balloon time, mortality, and false-positive activation.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.302744

7 January 2021